HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sang-Hyeon Nam Selected Research

tussilagone

4/2020Tussilagone Reduces Tumorigenesis by Diminishing Inflammation in Experimental Colitis-Associated Colon Cancer.
10/2018Tussilagone, a major active component in Tussilago farfara, ameliorates inflammatory responses in dextran sulphate sodium-induced murine colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sang-Hyeon Nam Research Topics

Disease

2Bone Resorption
08/2021 - 06/2019
2Colitis
04/2020 - 10/2018
2Inflammation (Inflammations)
04/2020 - 10/2018
2Neoplasms (Cancer)
04/2020 - 09/2017
1Osteoporosis
08/2021
1Bone Diseases (Bone Disease)
08/2021
1Body Weight (Weight, Body)
04/2020
1Carcinogenesis
04/2020
1Colitis-Associated Neoplasms
04/2020
1Weight Loss (Weight Reduction)
10/2018

Drug/Important Bio-Agent (IBA)

2tussilagoneIBA
04/2020 - 10/2018
2Dextran SulfateIBA
04/2020 - 10/2018
1OsteocalcinIBA
08/2021
1Ciclopirox (Loprox)FDA LinkGeneric
08/2021
1Collagen Type I (Type I Collagen)IBA
08/2021
1Therapeutic UsesIBA
04/2020
1AzoxymethaneIBA
04/2020
1LigandsIBA
06/2019
1SodiumIBA
10/2018
1Dextrans (Dextran)FDA Link
10/2018
1ziyuglycoside IIIBA
09/2017

Therapy/Procedure

1Ovariectomy (Oophorectomy)
08/2021